Literature DB >> 11494152

Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.

M Y Kim1, E Park, J H Park, D H Park, W S Moon, B H Cho, H S Shin, D G Kim.   

Abstract

Chronic hepatitis B virus (HBV) infection is known to be one of the major causes in the development of hepatocellular carcinoma (HCC), although the biomolecular mechanism(s) involved remain unclear. To identify the cellular gene(s) involved in HBV-associated hepatocarcinogenesis, we used the mRNA differential display method and examined three paired tumor and nontumor tissues, all of which had chromosomally integrated HBV-DNA through chronic infection. Using 240 different combinations of three one-base anchored oligo-dT primers and 80 arbitrary 13-mers, genes decreased or increased in expression more than twofold between each tumor tissue and its paired nontumor tissue were identified. Twenty-nine known genes and four novel genes were differentially over-expressed in the HCC tumor tissues. In contrast, 27 known genes and five novel genes were under-expressed in those tumor tissues. The nucleotide sequences of the nine novel gene fragments were determined and their expression patterns were examined in 40 HCC samples. HA61T2, PT18, HG63T1, and HG57T1 were preferentially over-expressed in 32 cases (80%, P<0.001), 24 cases (60%), 23 cases (57.5%) and 22 cases (55%) of the 40 tumor tissues, respectively. There was an increased frequency of HG57T1 over-expression in HCC patients with HBV-positive serology and low serum alpha-feto protein (AFP) levels (P<0.05). DNT10, PT8, PT19, ENT25 and HA6T4 were under-expressed in 26 cases (65%), 23 cases (57.5%), 21 cases (53%), 20 cases (50%) and 18 cases (45%) of the 40 tumor samples, respectively. There was a strong correlation of DNT10 under-expression with high serum AFP level in HCC patients, irrespective of HBV serology (P<0.01). HA6T4 was preferentially under-expressed in HCC tumors in patients with HBV-positive serology and high serum AFP levels (P<0.05). Thus, the functional analyses of the known and novel genes identified in this study should prove valuable to further understand the mechanism(s) of hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494152     DOI: 10.1038/sj.onc.1204626

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Genome-wide differences in hepatitis C- vs alcoholism-associated hepatocellular carcinoma.

Authors:  Celine Derambure; Cedric Coulouarn; Frederique Caillot; Romain Daveau; Martine Hiron; Michel Scotte; Arnaud Francois; Celia Duclos; Odile Goria; Marie Gueudin; Catherine Cavard; Benoit Terris; Maryvonne Daveau; Jean-Philippe Salier
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

2.  Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine.

Authors:  V Uma Bai; Ahmed Kaseb; Sheela Tejwani; George W Divine; Evelyn R Barrack; Mani Menon; Arthur B Pardee; G Prem-Veer Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205

3.  Identification of cellular genes showing differential expression associated with hepatitis B virus infection.

Authors:  Yasuo Fukuhara; Takeshi Suda; Makoto Kobayashi; Yasushi Tamura; Masato Igarashi; Nobuo Waguri; Hirokazu Kawai; Yutaka Aoyagi
Journal:  World J Hepatol       Date:  2012-04-27

4.  RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.

Authors:  Keo-Heun Lim; Kyun-Hwan Kim; Seong Il Choi; Eun-Sook Park; Seung Hwa Park; Kisun Ryu; Yong Kwang Park; So Young Kwon; Sung-Il Yang; Han Chu Lee; In-Kyung Sung; Baik L Seong
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

5.  Differential gene expression analysis of in vitro duck hepatitis B virus infected primary duck hepatocyte cultures.

Authors:  Sajith Nair; Devaki S Arathy; Aneesh Issac; Easwaran Sreekumar
Journal:  Virol J       Date:  2011-07-23       Impact factor: 4.099

6.  Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma.

Authors:  Xiao Fu; Yixuan Yang; Dazhi Zhang
Journal:  Liver Int       Date:  2021-12-07       Impact factor: 8.754

7.  Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.

Authors:  Jongmin Kim; Seok Joo Hong; Eun Kyung Lim; Yun-Suk Yu; Seung Whan Kim; Ji Hyeon Roh; In-Gu Do; Jae-Won Joh; Dae Shick Kim
Journal:  J Exp Clin Cancer Res       Date:  2009-02-16

8.  Aptamer-based Sandwich Assay and its Clinical Outlooks for Detecting Lipocalin-2 in Hepatocellular Carcinoma (HCC).

Authors:  Kyeong-Ah Lee; Ji-Young Ahn; Sang-Hee Lee; Simranjeet Singh Sekhon; Dae-Ghon Kim; Jiho Min; Yang-Hoon Kim
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

9.  Human Ribosomal Proteins RPeL27, RPeL43, and RPeL41 Are Upregulated in Nasopharyngeal Carcinoma Cell Lines.

Authors:  Edmund Ui-Hang Sim; Stella Li-Li Chan; Kher-Lee Ng; Choon-Weng Lee; Kumaran Narayanan
Journal:  Dis Markers       Date:  2016-11-28       Impact factor: 3.434

10.  Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus.

Authors:  Yan Ma; Jun Yu; Henry L Y Chan; Yang-chao Chen; Hua Wang; Ying Chen; Chu-yan Chan; Minnie Y Y Go; Sau-na Tsai; Sai-ming Ngai; Ka-fai To; Joanna H M Tong; Qing-Yu He; Joseph J Y Sung; Hsiang-fu Kung; Christopher H K Cheng; Ming-liang He
Journal:  Mol Cell Proteomics       Date:  2009-08-11       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.